112 related articles for article (PubMed ID: 38150944)
1. Quantification of fluticasone propionate in human plasma by LC-MS/MS and its application in the pharmacokinetic study of nasal spray at clinical doses.
Yamagata A; Adachi R; Yokokawa A; Furihata T; Shibasaki H
Drug Metab Pharmacokinet; 2024 Feb; 54():100541. PubMed ID: 38150944
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.
Derendorf H; Munzel U; Petzold U; Maus J; Mascher H; Hermann R; Bousquet J
Br J Clin Pharmacol; 2012 Jul; 74(1):125-33. PubMed ID: 22356350
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous analysis of glucocorticosteroid fluticasone propionate and its metabolite fluticasone propionate 17β-carboxylic acid in human plasma by UPLC-MS/MS at sub pg/mL level.
Nair SG; Patel DP; Sanyal M; Singhal P; Shrivastav PS
J Pharm Biomed Anal; 2017 Feb; 135():1-7. PubMed ID: 27987390
[TBL] [Abstract][Full Text] [Related]
4. Liquid chromatography-tandem mass spectrometry analysis of urinary fluticasone propionate-17beta-carboxylic acid for monitoring compliance with inhaled-fluticasone propionate therapy.
Korpi-Steiner NL; Netzel BC; Seegmiller JC; Hagan JB; Singh RJ
Steroids; 2010 Jan; 75(1):77-82. PubMed ID: 19883673
[TBL] [Abstract][Full Text] [Related]
5. A rapid and sensitive HPLC-APCI-MS/MS method determination of fluticasone in human plasma: application for a bioequivalency study in nasal spray formulations.
Byrro RM; César IC; de Santana e Silva Cardoso FF; Mundim IM; Teixeira Lde S; Bonfim RR; Gomes SA; Pianetti GA
J Pharm Biomed Anal; 2012 Mar; 61():38-43. PubMed ID: 22178434
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Comparison of the Pharmacokinetics and Bioavailability of Fluticasone Propionate Delivered via Xhance Exhalation Delivery System Versus Flonase Nasal Spray and Flovent HFA Inhalational Aerosol.
Messina JC; Offman E; Carothers JL; Mahmoud RA
Clin Ther; 2019 Nov; 41(11):2343-2356. PubMed ID: 31732149
[TBL] [Abstract][Full Text] [Related]
7. A high-throughput liquid chromatography tandem mass spectrometry method for the comparative determination of fluticasone propionate by reversed-phase liquid chromatography and capillary electrophoresis methods in pharmaceutical nasal sprays.
Sangoi Mda S; Wrasse M; D'Avila FB; Bernardi RM; de Oliveira PR; Dalmora SL; Bueno Rolim CM
Eur J Mass Spectrom (Chichester); 2009; 15(6):723-30. PubMed ID: 19940338
[TBL] [Abstract][Full Text] [Related]
8. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
Daley-Yates PT; Deans A; Mehta R; Sousa AR
Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
[TBL] [Abstract][Full Text] [Related]
9. A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma.
Krishnaswami S; Möllmann H; Derendorf H; Hochhaus G
J Pharm Biomed Anal; 2000 Feb; 22(1):123-9. PubMed ID: 10727131
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, Safety, and Tolerability of a New Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate Diskus(®) in Healthy Adults.
Vutikullird AB; Gillespie M; Song S; Steinfeld J
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):207-14. PubMed ID: 26624976
[TBL] [Abstract][Full Text] [Related]
11. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
Möllmann H; Wagner M; Krishnaswami S; Dimova H; Tang Y; Falcoz C; Daley-Yates PT; Krieg M; Stöckmann R; Barth J; Lawlor C; Möllmann AC; Derendorf H; Hochhaus G
J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
[TBL] [Abstract][Full Text] [Related]
12. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations.
Daley-Yates PT; Baker RC
Br J Clin Pharmacol; 2001 Jan; 51(1):103-5. PubMed ID: 11167672
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma.
Falcoz C; Horton J; Mackie AE; Harding SM; Daley-Yates PT
Clin Pharmacokinet; 2000; 39 Suppl 1():31-7. PubMed ID: 11140431
[TBL] [Abstract][Full Text] [Related]
14. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of orally administered micronised fluticasone propionate.
Falcoz C; Oliver R; McDowall JE; Ventresca P; Bye A; Daley-Yates PT
Clin Pharmacokinet; 2000; 39 Suppl 1():9-15. PubMed ID: 11140434
[TBL] [Abstract][Full Text] [Related]
16. Ultrasensitive and automated 1 pg/ml fluticasone propionate assay in human plasma using LC-MS/MS.
Ji AJ; Zhou D; Zhang S; Cawley MA; Fang X; Wu J
Bioanalysis; 2013 Feb; 5(4):423-35. PubMed ID: 23414376
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration.
Möllmann H; Wagner M; Meibohm B; Hochhaus G; Barth J; Stöckmann R; Krieg M; Weisser H; Falcoz C; Derendorf H
Eur J Clin Pharmacol; 1998 Feb; 53(6):459-67. PubMed ID: 9551705
[TBL] [Abstract][Full Text] [Related]
18. Determination of fluticasone propionate in nasal sprays by a validated stability-indicating MEKC method.
Sangoi Mda S; da Silva LM; D'Avila FB; Dalmora SL
J Chromatogr Sci; 2010 Sep; 48(8):641-6. PubMed ID: 20819293
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics.
Di Lorenzo G; Gervasi F; Drago A; Esposito Pellitteri M; Di Salvo A; Cosentino D; Potestio M; Colombo A; Candore G; Mansueto S; Caruso C
Clin Exp Allergy; 1999 Oct; 29(10):1367-77. PubMed ID: 10520057
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers.
Mackie AE; McDowall JE; Falcoz C; Ventresca P; Bye A; Daley-Yates PT
Clin Pharmacokinet; 2000; 39 Suppl 1():23-30. PubMed ID: 11140430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
